Pharmaceutical News RSS Feed - Pharmaceutical News

SCS therapy can be key to reducing use of opioids in patients battling chronic pain, study finds

SCS therapy can be key to reducing use of opioids in patients battling chronic pain, study finds

New research has found spinal cord stimulation (SCS) therapy can be key to reducing or stabilizing the use of opioids in patients battling chronic pain. [More]
Fixed-dose combinations could help patients stick to taking anti-hypertensive medicines

Fixed-dose combinations could help patients stick to taking anti-hypertensive medicines

There is value in starting off patients with high blood pressure on an all-in-one pill. In the long run, it may help them stick to taking the potentially life-saving medicines prescribed to them. [More]
New genital herpes vaccine candidate shows promising results in preclinical tests

New genital herpes vaccine candidate shows promising results in preclinical tests

Approximately 500 million people around the world are infected with the genital herpes virus known as herpes simplex virus 2 (HSV2). [More]
New research exposes cellular responses linked to bird flu vaccine

New research exposes cellular responses linked to bird flu vaccine

New research from Vanderbilt eavesdrops on gene expression in human immune system cells before and after vaccination against bird flu. [More]
FDA approves new oral medication for treating chronic idiopathic constipation in adult patients

FDA approves new oral medication for treating chronic idiopathic constipation in adult patients

The U.S. Food and Drug Administration today approved Trulance (plecanatide) for the treatment of Chronic Idiopathic Constipation (CIC) in adult patients. [More]
Statins could reduce threat of venous thromboembolism, research shows

Statins could reduce threat of venous thromboembolism, research shows

Statins could hold the key to eradicating one of the most preventable causes of hospital deaths after researchers uncovered a new role for the cholesterol-lowering pill. [More]
Eosera introduces new solution for earwax impaction

Eosera introduces new solution for earwax impaction

EOSERA™, Inc. , a Dallas-based biotechnology innovator founded by two veterans of the pharmaceutical industry, today announced the introduction of Earwax MD—the ideal solution for those who dread the time, worry, and expense of a doctor’s visit to clear their ears of burdensome earwax impaction. [More]
New way of repurposing existing drugs could unearth promising treatments for Parkinson’s disease

New way of repurposing existing drugs could unearth promising treatments for Parkinson’s disease

By bringing together cutting-edge stem cell technologies and computational biology, researchers at Oxford University have developed a unique way to identify existing drugs that could potentially be repurposed for treating Parkinson’s. [More]
OSU scientists develop new weapon to combat antibiotic-resistant germs

OSU scientists develop new weapon to combat antibiotic-resistant germs

Oregon State University researchers have developed a new weapon in the battle against antibiotic-resistant germs - a molecule that neutralizes the bugs' ability to destroy the antibiotic. [More]
Exercise helps mitigate side effects of AIs in breast cancer survivors

Exercise helps mitigate side effects of AIs in breast cancer survivors

A researcher at Syracuse University has simple advice for breast cancer survivors struggling with the side effects of Aromatase Inhibitors (AIs): exercise. [More]
Antidepressant use during pregnancy could increase risk of birth defects in baby, study reveals

Antidepressant use during pregnancy could increase risk of birth defects in baby, study reveals

A new Université de Montréal study in the British Medical Journal reveals that antidepressants prescribed to pregnant women could increase the chance of having a baby with birth defects. [More]
Scientists discover adverse, unpredictable side effects of approved MS therapy

Scientists discover adverse, unpredictable side effects of approved MS therapy

The multiple sclerosis (MS) therapy alemtuzumab can trigger severe, unpredictable side effects. [More]
Colorado medical students express support for legal use of marijuana

Colorado medical students express support for legal use of marijuana

In the first study of its kind, University of Colorado School of Medicine students expressed support for the legal use of marijuana, including for physical and mental health reasons. [More]
BetterYou magnesium can raise cellular mineral levels faster than traditional tablets

BetterYou magnesium can raise cellular mineral levels faster than traditional tablets

Low magnesium levels are leading to a worrying level of undissolved calcium and increased heavy metal toxicity which can severely impact on our health and wellbeing, say mineral analysis experts. [More]
Improving fungal disease diagnostics could help battle against antimicrobial resistance

Improving fungal disease diagnostics could help battle against antimicrobial resistance

Ignorance of fungal disease and lack of diagnostics across the world is causing doctors to unknowingly overprescribe antibiotics a new report warns. [More]
Fraunhofer scientists develop new method to irradiate pathogens using low-energy-electrons

Fraunhofer scientists develop new method to irradiate pathogens using low-energy-electrons

Many vaccines contain viruses that are inactivated to prevent them from harming recipients. [More]
TGen scientists identify potent inhibitory compound for treatment against glioblastoma

TGen scientists identify potent inhibitory compound for treatment against glioblastoma

A study led by scientists at the Translational Genomics Research Institute has identified "a potent inhibitory compound" in the elusive hunt for an improved treatment against glioblastoma, the most common and deadly type of adult brain cancer. [More]
Georgia State University, GeoVax join forces to advance development of Hepatitis B therapeutic vaccine

Georgia State University, GeoVax join forces to advance development of Hepatitis B therapeutic vaccine

The Georgia State University Research Foundation has entered into a research collaboration agreement with GeoVax Labs, Inc., a Georgia-based biotechnology company developing human vaccines, to advance development of a therapeutic vaccine for treatment of chronic Hepatitis B infections. [More]
Penn researchers discover antimicrobial that thwarts Zika viral entry into human cells

Penn researchers discover antimicrobial that thwarts Zika viral entry into human cells

A panel of small molecules that inhibit Zika virus infection, including one that stands out as a potent inhibitor of Zika viral entry into relevant human cell types, was discovered by researchers from the Perelman School of Medicine at the University of Pennsylvania. [More]
Analgesic effects of opioids can be mediated via immune cells

Analgesic effects of opioids can be mediated via immune cells

Opioids are the most powerful painkillers. Researchers at the Charité - Universitätsmedizin Berlin have now found that the analgesic effects of opioids are not exclusively mediated by opioid receptors in the brain, but can also be mediated via the activation of receptors in immune cells. [More]
Advertisement
Advertisement